| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |